← All trials
NCT05532280
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 28, 2020
- Primary completion
- Jan 14, 2021
- Completion date
- Jan 14, 2021
- First posted
- Sep 8, 2022
- Last posted
- Sep 8, 2022
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Future University in EgyptLead sponsor
- Future University in EgyptOverall official - principal investigator
- Future University in EgyptReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.